Biotech Sector Raises $23bn In Venture Capital In 2018
While major biotech indices went south in 2018, VC enthusiasm for biotech remained bullish. Biotech companies raised a record $22.83bn in 2018.
You may also be interested in...
With UK biotech venture capital investment at its highest level to date, biotech company building is showing no let up, with almost half of all UK biotech companies formed within the last three years.
In 2018, while biotech venture activity spoke mainly with an American accent, China emerged as the world’s third most active cluster, while the UK led the way in Europe.
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.